Publications by authors named "Daniela Meco"

Claim this Profile
E
Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
Daniela Meco, Giorgio Attinà, Stefano Mastrangelo, Pierluigi Navarra, Antonio Ruggiero

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF.
Ornella Franzese, Angela M Di Francesco, Daniela Meco, Grazia Graziani, Gabriella Cusano

Pathol Oncol Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells.
Linda Melotti, Daniela Meco, Alessandra Battaglia, Alexia Buzzonetti, Maurizio Martini

Oncol Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models.
Tiziana Servidei, Daniela Meco, Maurizio Martini, Alessandra Battaglia, Alessia Granitto

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction.
Daniela Meco, Angela Maria Di Francesco, Linda Melotti, Antonio Ruggiero, Riccardo Riccardi

J Cell Physiol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel - Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.
Tiziana Servidei, Daniela Meco, Valentina Muto, Alessandro Bruselles, Andrea Ciolfi

Cancer Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?
Alessandra Ciucci, Daniela Meco, Ilaria De Stefano, Daniele Travaglia, Gian Franco Zannoni

PLoS One· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models.
Daniela Meco, Tiziana Servidei, Giuseppe Lamorte, Elena Binda, Vincenzo Arena

Neuro Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
Daniela Meco, Angela Maria Di Francesco, Gabriella Cusano, Federica Bucci, Filomena Pierri

Cancer Chemother Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models.
Tiziana Servidei, Daniela Meco, Nadia Trivieri, Valentina Patriarca, Valerio Gaetano Vellone

Int J Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models.
Angela Maria Di Francesco, Paolo Ubezio, Anna Rita Torella, Daniela Meco, Filomena Pierri

Invest New Drugs· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.
Giuliana Cassinelli, Valentina Zuco, Giovanna Petrangolini, Michelandrea De Cesare, Monica Tortoreto, Daniela Meco

Biochem Pharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma.
Daniela Meco, Tiziana Servidei, Gian Franco Zannoni, Enrica Martinelli, Maria Grazia Prisco

Transl Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts.
Massimo Zucchetti, Daniela Meco, Angela Maria Di Francesco, Tiziana Servidei, Valentina Patriarca

Cancer Chemother Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.
Daniela Meco, Tiziana Servidei, Anna Riccardi, Cristiano Ferlini, Gabriella Cusano

Neuro Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models.
Heather P McDowell, Daniela Meco, Anna Riccardi, Barbara Tanno, Anna C Berardi

Int J Cancer· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
Angela Maria Di Francesco, Daniela Meco, Anna Rita Torella, Giuseppe Barone, Maurizio D'Incalci

Biochem Pharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array.
Kwong-Kwok Wong, Yvonne T M Tsang, Yi-Mieng Chang, Jack Su, Angela M Di Francesco, Daniela Meco

Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of imatinib mesylate in neuroblastoma xenografts.
Daniela Meco, Anna Riccardi, Tiziana Servidei, Josef Brueggen, Marco Gessi

Cancer Lett· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan.
Angela Maria Di Francesco, Anna Riccardi, Giuseppe Barone, Sergio Rutella, Daniela Meco

Biochem Pharmacol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft.
Anna Riccardi, Daniela Meco, Paolo Ubezio, Giorgio Mazzarella, Mirko Marabese

Anticancer Drugs· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.
Sarah Donald, Richard D Verschoyle, Peter Greaves, Timothy W Gant, Tina Colombo, Daniela Meco

Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies.
Daniela Meco, Tina Colombo, Paolo Ubezio, Massimo Zucchetti, Marco Zaffaroni

Cancer Chemother Pharmacol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis